CITIGROUP INC - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 143 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q2 2016. The put-call ratio across all filers is 1.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2017$120,000
-84.3%
97,169
-60.7%
0.00%
Q1 2017$762,000
-64.4%
247,235
-52.9%
0.00%
-100.0%
Q4 2016$2,143,000
+214.2%
525,425
+389.7%
0.00%
Q3 2016$682,000
+367.1%
107,291
+295.6%
0.00%
Q2 2016$146,000
-83.4%
27,121
-74.2%
0.00%
-100.0%
Q1 2016$879,000
+467.1%
105,007
+435.2%
0.00%
Q4 2015$155,000
-78.0%
19,620
-76.3%
0.00%
-100.0%
Q3 2015$704,000
+43.7%
82,744
+108.2%
0.00%
Q2 2015$490,000
-14.9%
39,740
-18.0%
0.00%
-100.0%
Q1 2015$576,000
-11.0%
48,446
-15.4%
0.00%0.0%
Q4 2014$647,000
+304.4%
57,266
+213.2%
0.00%
Q3 2014$160,000
-19.2%
18,282
-32.9%
0.00%
Q2 2014$198,000
-1.5%
27,235
-31.8%
0.00%
Q1 2014$201,000
-33.4%
39,946
-29.2%
0.00%
Q4 2013$302,000
+297.4%
56,414
+183.2%
0.00%
Q3 2013$76,000
+72.7%
19,923
+204.9%
0.00%
Q2 2013$44,0006,5350.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q2 2016
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 5,000,000$20,400,0004.19%
Consonance Capital Management LP 9,067,998$36,997,0004.06%
Lagoda Investment Management, L.P. 1,522,529$6,212,0002.13%
INDUS CAPITAL PARTNERS, LLC 1,050,000$4,284,0000.56%
WESTFIELD CAPITAL MANAGEMENT CO LP 9,072,877$37,017,0000.32%
GARRISON BRADFORD & ASSOCIATES INC 77,700$317,0000.29%
Cannell & Co. 1,572,978$6,418,0000.23%
Virtus ETF Advisers LLC 179,625$733,0000.22%
LeJeune Puetz Investment Counsel LLC 3,976$161,0000.12%
STONERIDGE INVESTMENT PARTNERS LLC 221,838$905,0000.12%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders